CNC
CENTENE CORP
NYSE · Healthcare · Medical - Healthcare Plans · US
$65.11
−2.97%Next report
Analyst consensus
- Next report date
- Oct 27, 2026
- EPS estimate
- $0.07
- Revenue estimate
- $47.6B
Latest reported
- Last report date
- Jul 28, 2026
- EPS actual
- $2.51
- EPS estimate
- $1.09
- Revenue actual
- $53.6B
- Revenue estimate
- $48.1B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +164.6%
- Revenue beats (12Q)
- 12
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $73
- PT range
- $65 – $80
- Analysts
- 10
5 Buy5 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 28, 2026 | $1.09 | $2.51 | Beat 130.28% | $53.6B |
| Apr 28, 2026 | $1.87 | $3.37 | Beat 80.21% | $49.9B |
| Feb 6, 2026 | -$1.22 | -$1.19 | Beat 2.46% | $49.7B |
| Oct 29, 2025 | -$0.14 | $0.50 | Beat 445.42% | $49.7B |
| Jul 25, 2025 | $0.11 | -$0.16 | Miss -243.37% | $48.7B |
| Apr 25, 2025 | $2.52 | $2.90 | Beat 15.08% | $46.6B |
| Feb 4, 2025 | $0.44 | $0.80 | Beat 81.82% | $40.8B |
| Oct 25, 2024 | $1.33 | $1.62 | Beat 21.80% | $42.0B |
| Jul 26, 2024 | $2.07 | $2.42 | Beat 16.91% | $39.8B |
| Apr 26, 2024 | $2.08 | $2.26 | Beat 8.65% | $40.4B |
| Feb 6, 2024 | $0.43 | $0.45 | Beat 4.65% | $39.5B |
| Jul 28, 2023 | $2.03 | $2.10 | Beat 3.45% | $37.6B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 27, 2026